Muna Therapeutics ApS Financials, key figures and credit report
Gross profit -60 636.0 kDKK FY 2025 +51.4% vs 2024
EBIT -94 615.0 kDKK FY 2025 +42.2% vs 2024
Net debt -35 636.0 kDKK FY 2025 -867.6% vs 2024
Quick ratio 1.5 FY 2025 -1.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -49 692.75 | -98 234.04 | - 110 624.44 | - 124 746.00 | -60 636.00 |
| Employee benefit expenses | -8 756.25 | -20 425.84 | -25 334.09 | -28 780.00 | -29 340.00 |
| Other operating expenses | - 125.00 | ||||
| Total depreciation | -3 020.09 | -3 790.15 | -6 558.99 | -10 073.00 | -4 639.00 |
| EBIT | -61 469.09 | - 122 450.03 | - 142 517.52 | - 163 724.00 | -94 615.00 |
| Other financial income | 177.75 | 301.44 | 2 265.74 | 4 205.00 | 5 534.00 |
| Other financial expenses | - 385.05 | - 585.72 | - 561.67 | -10 299.00 | -42 114.00 |
| Net income from associates (fin.) | -4 706.41 | -10 448.03 | -4 937.26 | ||
| Pre-tax profit | -66 382.79 | - 133 182.35 | - 145 750.71 | - 169 818.00 | - 131 195.00 |
| Income taxes | 4 864.53 | 5 500.00 | 5 430.74 | -5 013.00 | 5 500.00 |
| Net earnings | -61 518.26 | - 127 682.35 | - 140 319.97 | - 174 831.00 | - 125 695.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible rights | 13 066.58 | 17 417.59 | 12 060.19 | 3 236.00 | 1 079.00 |
| Intangible assets total | 13 066.58 | 17 417.59 | 12 060.19 | 3 236.00 | 1 079.00 |
| Buildings | 100.89 | 80.37 | 419.00 | 322.00 | |
| Machinery and equipment | 1 357.64 | 3 117.93 | 3 825.54 | 2 812.00 | 1 751.00 |
| Other tangible assets | 3 611.00 | ||||
| Tangible assets total | 1 357.64 | 3 218.82 | 3 905.91 | 3 231.00 | 5 684.00 |
| Holdings in group member companies | 53 692.28 | 43 274.41 | 38 306.65 | 27 000.00 | 27 000.00 |
| Investments total | 53 737.81 | 43 743.43 | 39 331.39 | 28 420.00 | 28 427.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 3 899.00 | 3 935.00 | |||
| Prepayments and accrued income | 731.88 | 2 379.39 | 2 029.95 | 931.00 | 13 648.00 |
| Current other receivables | 1 292.57 | 2 506.99 | 2 340.17 | 15 322.00 | 2 653.00 |
| Current deferred tax assets | 5 344.82 | 9 981.65 | 5 500.00 | 5 500.00 | |
| Short term receivables total | 7 369.27 | 14 868.03 | 9 870.12 | 20 152.00 | 25 736.00 |
| Cash and bank deposits | 108 532.38 | 168 269.81 | 103 042.87 | 113 499.00 | 250 198.00 |
| Cash and cash equivalents | 108 532.38 | 168 269.81 | 103 042.87 | 113 499.00 | 250 198.00 |
| Balance sheet total (assets) | 184 063.68 | 247 517.68 | 168 210.49 | 168 538.00 | 311 124.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 675.98 | 1 061.87 | 1 201.80 | 1 342.00 | 1 343.00 |
| Other reserves | 6.67 | ||||
| Retained earnings | 223 155.27 | 328 658.76 | 266 078.03 | 179 575.00 | 4 014.00 |
| Profit of the financial year | -61 518.26 | - 127 682.35 | - 140 319.97 | - 174 831.00 | - 125 695.00 |
| Shareholders equity total | 162 312.99 | 202 044.95 | 126 959.86 | 6 086.00 | - 120 338.00 |
| Provisions | 23.49 | 140.00 | |||
| Non-current loans from credit institutions | 91 246.00 | 198 690.00 | |||
| Non-current advances received | 3 686.00 | ||||
| Non-current other liabilities | 15.75 | 22 971.00 | 47 399.00 | ||
| Non-current liabilities total | 15.75 | 114 217.00 | 249 775.00 | ||
| Current trade creditors | 11 755.77 | 13 491.91 | 18 118.72 | 16 715.00 | 14 761.00 |
| Current owed to group member | 7 532.87 | 16 600.98 | 12 036.45 | 18 570.00 | 15 872.00 |
| Short-term deferred tax liabilities | 5 013.00 | ||||
| Other non-interest bearing current liabilities | 2 462.05 | 3 488.91 | 5 184.42 | 5 197.00 | 6 279.00 |
| Accruals and deferred income | 11 851.69 | 5 911.05 | 2 740.00 | 144 635.00 | |
| Current liabilities total | 21 750.70 | 45 433.49 | 41 250.63 | 48 235.00 | 181 547.00 |
| Balance sheet total (liabilities) | 184 063.68 | 247 517.68 | 168 210.49 | 168 538.00 | 311 124.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated